Sensient Technologies vs Westlake Chemical Partners LP
SXT and WLKP side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SXT and WLKP compare
Sensient Technologies is the larger company, worth 6.6 times as much as Westlake Chemical Partners LP ($4.9B against $740M).
Westlake Chemical Partners LP grew revenue faster over the last twelve months (12.1% versus 9.5% for Sensient Technologies).
Sensient Technologies keeps more of each dollar of sales as profit, with a net margin of 9.7% compared with 4.7% at Westlake Chemical Partners LP.
Both pay dividends: Sensient Technologies yields 1.1% and Westlake Chemical Partners LP 6.7%.
Sensient Technologies scores higher on the StockData Score (15 against 12 for Westlake Chemical Partners LP), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SXT | WLKP |
|---|---|---|
| Size and price | ||
| Market cap | $4.9B | $740M |
| Share price | $114.59 | $21.00 |
| Change, 1 year | 20.3% | 11.8% |
| Change, 5 years | 14.7% | −13.3% |
| Beta (5Y) | 0.78 | 0.18 |
| Employees | 4,070 | – |
| StockData Score | ||
| Total score | 15 (better) | 12 |
| Valuation score | 1 | 3 (better) |
| Growth score | 4 (better) | 2 |
| Performance score | 4 (better) | 1 |
| Health score | 3 | 3 |
| Dividend score | 3 | 3 |
| Valuation | ||
| P/E | 28.9× | – |
| P/S | 2.8× | 0.6× (better) |
| P/B | 3.8× | – |
| EV/EBITDA | 17.7× | 1.4× (better) |
| P/FCF | – | 1.8× |
| FCF yield | −0.36% | 55.3% (better) |
| Fair value | $102.54 | $196.61 |
| Margin of safety | −11.7% | 89.3% (better) |
| Growth | ||
| Revenue growth (TTM) | 9.5% | 12.1% (better) |
| Revenue growth, 5Y average | 3.9% (better) | 3.8% |
| Net income growth (TTM) | 21.7% (better) | 9.4% |
| EPS growth (TTM) | 21.4% | – |
| EPS growth, 5Y average | 4.1% | – |
| Profitability | ||
| Gross margin | 35.1% (better) | 31.2% |
| Operating margin | 14.5% | 28.8% (better) |
| Net margin | 9.7% (better) | 4.7% |
| FCF margin | −1.0% | 33.1% (better) |
| Return on equity | 13.7% | – |
| Return on invested capital | 10.0% | – |
| Financial health | ||
| Debt / equity | 0.61 | – |
| Net debt / EBITDA | 2.36 | – |
| Interest coverage | 8.0× | 16.4× (better) |
| Current ratio | 3.97 (better) | 3.44 |
| Altman Z-score | 5.07 (better) | 3.08 |
| Piotroski F-score | 6 (better) | 5 |
| Dividends and buybacks | ||
| Dividend yield | 1.1% | 6.7% (better) |
| Payout ratio | 41.2% | – |
| Years of dividend growth | 0 | – |
| Dividend growth, 5Y average | 1.0% | – |
| Shareholder yield | 1.1% | 6.7% (better) |
| Ownership | ||
| Held by institutions | 99.0% | 29.1% |
| Held by insiders | 26.0% | 44.3% |
| Insider net buying, 12 months | −$234M | – |
| Short interest, % of float | 3.1% | 0.75% |
Go deeper
- SXT stock overview
- SXT income statement
- SXT valuation and score
- WLKP stock overview
- WLKP income statement
- WLKP valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.